SCHEMBL2582061

SCHEMBL2582061

CCC(COCC(=O)N(C1CCCCC1)C1CCCCC1)(COCC(=O)N(C1CCCCC1)C1CCCCC1)COCC(=O)N(C1CCCCC1)C1CCCCC1

nearest known ligand 0.44

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 4/20 0.44
▸ MEN1 O00255 3/20 0.43
▸ TSHR P16473 3/20 0.42
▸ ALDH1A1 P00352 4/20 0.42
▸ POLB P06746 1/20 0.42
▸ MAPK1 P28482 1/20 0.42
▸ NPSR1 Q6W5P4 2/20 0.39
▸ LMNA P02545 2/20 0.39
▸ L3MBTL1 Q9Y468 1/20 0.38
▸ S1PR1 P21453 2/20 0.35
▸ S1PR3 Q99500 2/20 0.35
▸ XBP1 P17861 1/20 0.35
▸ ADH1C P00326 1/20 0.35
▸ ADH1A P07327 1/20 0.35
▸ GAA P10253 1/20 0.35
▸ KDM4E B2RXH2 1/20 0.34
▸ NPC1 O15118 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2579241 0.89 KMT2A (0.38) KMT2AMEN1TSHRALDH1A1POLB
SCHEMBL27349992 0.88 ALDH1A1 (0.49) KMT2AMEN1TSHRALDH1A1LMNA
SCHEMBL27349878 0.85 KMT2A (0.39) KMT2AMEN1TSHRALDH1A1POLB
SCHEMBL27351020 0.84 KMT2A (0.34) KMT2AMEN1TSHRALDH1A1POLB
SCHEMBL9761192 0.84 KMT2A (0.44) KMT2AMEN1TSHRALDH1A1POLB
SCHEMBL6002977 0.82 KMT2A (0.48) KMT2AMEN1TSHRALDH1A1POLB
SCHEMBL2842929 0.81 KMT2A (0.53) KMT2AMEN1TSHRALDH1A1POLB
SCHEMBL701404 0.81 KMT2A (0.53) KMT2AMEN1TSHRALDH1A1POLB
SCHEMBL27349884 0.79 KMT2A (0.37) KMT2AMEN1TSHRALDH1A1POLB
SCHEMBL27349991 0.76 SMN1; SMN2 (0.35) KMT2AMEN1TSHRALDH1A1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025120574-A1 SELECTIVE MEMBRANE SYSTEM AND METHOD FOR DESALINATION AND MINERAL RECOVERY NEOM COMPANY (SA) 2025-06-12 — — WO claimed
US-20020038762-A1 Solid-state ion selective electrodes and methods of producing the same ADVANCED MONITORING SYSTEMS LTD. 2002-04-04 — — US claimed
US-20260126393-A1 METHOD FOR DETERMINING THE LITHIUM CONTENT IN A BIOLOGICAL FLUID CENTRE NAT RECH SCIENT (FR) 2026-05-07 — — US disclosed
US-20260042036-A1 METHOD FOR SELECTIVELY EXTRACTING A SALT TO BE EXTRACTED FROM SALTWATER OR BRINE ADIONICS (FR) 2026-02-12 — — US disclosed
EP-4684041-A1 RECOVERY OF LI-SALTS FROM ORES K-UTEC AG Salt Technologies (DE) 2026-01-28 — — EP disclosed
EP-4673239-A2 HYDROPHOBIC ORGANIC LIQUID COMPOSITION FOR THE SELECTIVE EXTRACTION OF A LITHIUM SALT Adionics (FR) 2026-01-07 — — EP disclosed
US-20250258105-A1 ION DETECTION WITHOUT OPTICAL INTERFERENCE FROM SAMPLES UNIV VIRGINIA COMMONWEALTH (US) 2025-08-14 — — US disclosed
EP-4599234-A1 METHOD FOR DETERMINING THE LITHIUM CONTENT IN A BIOLOGICAL FLUID Centre National de la Recherche Scientifique (FR) 2025-08-13 — — EP disclosed
EP-4580489-A1 DEVICES AND METHODS FOR MEASURING A CONCENTRATION OF A TARGET ANALYTE IN A BIOLOGICAL FLUID IN VIVO DexCom, Inc. (US) 2025-07-09 — — EP disclosed
WO-2025120574-A1 SELECTIVE MEMBRANE SYSTEM AND METHOD FOR DESALINATION AND MINERAL RECOVERY NEOM COMPANY (SA) 2025-06-12 — — WO disclosed
EP-4531680-A1 SENSING SYSTEMS AND METHODS FOR DIAGNOSING KIDNEY DISEASE Dexcom, Inc. (US) 2025-04-09 — — EP disclosed
US-20230390466-A1 SYSTEMS AND METHODS FOR OPTIMIZING TREATMENT USING PHYSIOLOGICAL PROFILES DEXCOM, INC. 2023-12-07 — — US disclosed
WO-2023205630-A1 ION DETECTION WITHOUT OPTICAL INTERFERENCE FROM SAMPLES VIRGINIA COMMONWEALTH UNIVERSITY (US) 2023-10-26 — — WO disclosed
WO-2023164584-A1 SENSING SYSTEMS AND METHODS FOR PROVIDING DECISION SUPPORT AROUND KIDNEY HEALTH AND/OR DIABETES DEXCOM, INC. (US) 2023-08-31 — — WO disclosed
EP-4172608-A1 METHOD OF FORMING AN IONIC SENSOR AND CORRESPONDING APPARATUS Technische Universität München (DE) 2023-05-03 — — EP disclosed
US-20230005672-A1 CHELATOR-IN-IONIC LIQUID ELECTROLYTES PRESIDENT AND FELLOWS OF HARVARD COLLEGE 2023-01-05 — — US disclosed
WO-2021067770-A1 CHELATOR-IN-IONIC LIQUID ELECTROLYTES PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2021-04-08 — — WO disclosed
US-8999561-B2 Materials for electrochemical device safety UCHICAGO ARGONNE, LLC (US) 2015-04-07 — — US disclosed
US-20110281154-A1 MATERIALS FOR ELECTROCHEMICAL DEVICE SAFETY ENERGY, UNITED STATES DEPARTMENT OF 2011-11-17 — — US disclosed
US-20020038762-A1 Solid-state ion selective electrodes and methods of producing the same ADVANCED MONITORING SYSTEMS LTD. 2002-04-04 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260126393-A1 METHOD FOR DETERMINING THE LITHIUM CONTENT IN A BIOLOGICAL FLUID ORAI1, CA2, KCNN4 KMT2A 4250/4885MEN1 317/4885TSHR 1234/4885
US-20260042036-A1 METHOD FOR SELECTIVELY EXTRACTING A SALT TO BE EXTRACTED FROM SALTWATER OR BRINE PRKAR2B, PRKAR2A, PRKCD KMT2A 3133/4885MEN1 2902/4885TSHR 1039/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback